• Wintrust Business Minute: AbbVie shares drop after disappointing drug trials

  • 2024/11/11
  • 再生時間: 1分未満
  • ポッドキャスト

Wintrust Business Minute: AbbVie shares drop after disappointing drug trials

  • サマリー

  • Steve Grzanich has the business news of the day with the Wintrust Business Minute. Shares of AbbVie have dropped sharply after disappointing trials for its drug to treat schizophrenia. The drug, emraclidine, failed to meet the primary goal of treating symptoms of the mental illness. The drug was part of two mid-stage trials which shows […]
    続きを読む 一部表示

あらすじ・解説

Steve Grzanich has the business news of the day with the Wintrust Business Minute. Shares of AbbVie have dropped sharply after disappointing trials for its drug to treat schizophrenia. The drug, emraclidine, failed to meet the primary goal of treating symptoms of the mental illness. The drug was part of two mid-stage trials which shows […]

Wintrust Business Minute: AbbVie shares drop after disappointing drug trialsに寄せられたリスナーの声

カスタマーレビュー:以下のタブを選択することで、他のサイトのレビューをご覧になれます。